With regard to patients with proliferative glomerulonephritis, 70.6% of patients with CresGN, 41.7% of patients with MPGN, 9.2% of patients with IgAN, and no patients with non-IgA mesPGN or AGN manifested thrombinuria (Fig. 1A). This evidence concerns the gene CD79A and primary membranoproliferative glomerulonephritis.